Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 975032, 10 pages
http://dx.doi.org/10.1155/2013/975032
Research Article

Retinal Pigment Epithelial Cells Express a Functional Receptor for Glucagon-Like Peptide-1 (GLP-1)

1Department of Internal Medicine, University of Genoa, IRCCS Azienda Ospedaliera Universitaria San Martino–IST Istituto Nazionale per la Ricerca sul Cancro, 6 Viale Benedetto XV, 16132 Genoa, Italy
2First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, IRCCS Azienda Ospedaliera Universitaria San Martino–IST Istituto Nazionale per la Ricerca sul Cancro, 6 Viale Benedetto XV, 16132 Genoa, Italy
3Division of Cardiology, Geneva University Hospitals, Faculty of Medicine, Foundation for Medical Researches, 64 Avenue Roseraie, 1211 Geneva, Switzerland

Received 25 July 2013; Accepted 30 September 2013

Academic Editor: Dorota Raczyńska

Copyright © 2013 Alessandra Puddu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Holst, “The physiology of glucagon-like peptide 1,” Physiological Reviews, vol. 87, no. 4, pp. 1409–1439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. L. L. Baggio and D. J. Drucker, “Biology of Incretins: GLP-1 and GIP,” Gastroenterology, vol. 132, no. 6, pp. 2131–2157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Puddu, D. Storace, A. Durante, P. Odetti, and G. L. Viviani, “Glucagon-like peptide-1 counteracts the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T 15,” Biochemical and Biophysical Research Communications, vol. 398, no. 3, pp. 462–466, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Puddu, F. Mach, A. Nencioni, G. L. Viviani, and F. Montecucco, “An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes,” Mediators of Inflammation, vol. 2013, Article ID 591056, 9 pages, 2013. View at Publisher · View at Google Scholar
  5. B. L. Wajchenberg, “Clinical approaches to preserve β-cell function in diabetes,” Advances in Experimental Medicine and Biology, vol. 654, pp. 515–535, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Vilsboll, “The effects of glucagon-like peptide-1 on the beta cell,” Diabetes, Obesity and Metabolism, vol. 11, supplement 3, pp. 11–18, 2009. View at Google Scholar
  7. I. A. Urusova, L. Farilla, H. Hui, E. D'Amico, and R. Perfetti, “GLP-1 inhibition of pancreatic islet cell apoptosis,” Trends in Endocrinology and Metabolism, vol. 15, no. 1, pp. 27–33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Thorens, “Expression cloning of the pancreatic β cell receptor for the gluco- incretin hormone glucagon-like peptide 1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 18, pp. 8641–8645, 1992. View at Google Scholar · View at Scopus
  9. M. E. Doyle and J. M. Egan, “Mechanisms of action of glucagon-like peptide 1 in the pancreas,” Pharmacology and Therapeutics, vol. 113, no. 3, pp. 546–593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Quoyer, C. Longuet, C. Broca et al., “GLP-1 mediates antiapoptotic effect by phosphorylating bad through a β-arrestin 1-mediated ERK1/2 activation in pancreatic β-cells,” Journal of Biological Chemistry, vol. 285, no. 3, pp. 1989–2002, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Montrose-Rafizadeh, P. Avdonin, M. J. Garant et al., “Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells,” Endocrinology, vol. 140, no. 3, pp. 1132–1140, 1999. View at Google Scholar · View at Scopus
  12. D. J. Drucker and M. A. Nauck, “The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes,” The Lancet, vol. 368, no. 9548, pp. 1696–1705, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Fu, H. Y. Kuang, M. Hao, X. Y. Gao, Y. Liu, and N. Shao, “Protection of exenatide for retinal ganglion cells with different glucose concentrations,” Peptides, vol. 37, pp. 25–31, 2011. View at Google Scholar
  14. Y. Zhang, Q. Wang, J. Zhang, X. Lei, G. T. Xu, and W. Ye, “Protection of exendin-4 analogue in early experimental diabetic retinopathy,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 247, no. 5, pp. 699–706, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Zhang, J. Zhang, Q. Wang et al., “Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats,” Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 278–285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. D. A. Antonetti, A. J. Barber, S. K. Bronson et al., “Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease,” Diabetes, vol. 55, no. 9, pp. 2401–2411, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. T. W. Gardner, D. A. Antonetti, A. J. Barber, K. F. LaNoue, and S. W. Levison, “Diabetic retinopathy: more than meets the eye,” Survey of Ophthalmology, vol. 47, supplement 2, pp. S253–S262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Zhang, Y. Wu, Y. Jin et al., “Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes,” Investigative Ophthalmology and Visual Science, vol. 49, no. 2, pp. 732–742, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Bok, “The retinal pigment epithelium: a versatile partner in vision,” Journal of Cell Science, vol. 17, pp. 189–195, 1993. View at Google Scholar · View at Scopus
  20. O. Strauss, “The retinal pigment epithelium in visual function,” Physiological Reviews, vol. 85, no. 3, pp. 845–881, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Buteau, R. Roduit, S. Susini, and M. Prentki, “Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)- cells,” Diabetologia, vol. 42, no. 7, pp. 856–864, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. N. R. Adams, “Pathological changes in the tissues of infertile ewes with clover disease,” Journal of Comparative Pathology, vol. 86, no. 1, pp. 29–35, 1976. View at Google Scholar · View at Scopus
  23. G. Luciano Viviani, A. Puddu, G. Sacchi et al., “Glycated fetal calf serum affects the viability of an insulin-secreting cell line in vitro,” Metabolism, vol. 57, no. 2, pp. 163–169, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. B. A. Hemmings and D. F. Restuccia, “PI3K-PKB/Akt pathway, cold spring harb,” Perspectives in Biology and Medicine, vol. 4, Article ID a011189, 2012. View at Google Scholar
  25. J. Buteau, S. Foisy, E. Joly, and M. Prentki, “Glucagon-like peptide 1 induces pancreatic β-cell proliferation via transactivation of the epidermal growth factor receptor,” Diabetes, vol. 52, no. 1, pp. 124–132, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Kimura, M. Okouchi, T. Kato et al., “Epidermal growth factor receptor transactivation is necessary for glucagon-like Peptide-1 to protect PC12 cells from apoptosis,” Neuroendocrinology, vol. 97, pp. 300–308, 2013. View at Google Scholar
  27. A. Kvanta, “Expression and regulation of vascular endothelial growth factor in choroidal fibroblasts,” Current Eye Research, vol. 14, no. 11, pp. 1015–1020, 1995. View at Google Scholar · View at Scopus
  28. R. H. Foxton, A. Finkelstein, S. Vijay et al., “VEGF-A is necessary and sufficient for retinal neuroprotection in models of experimental glaucoma,” The American Journal of Pathology, vol. 182, pp. 1379–1390, 2013. View at Google Scholar
  29. R. Simó, M. Villarroel, L. Corraliza, C. Hernández, and M. Garcia-Ramírez, “The retinal pigment epithelium: something more than a constituent of the blood-retinal barrier-implications for the pathogenesis of diabetic retinopathy,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 190724, 15 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. E. MacDonald and M. B. Wheeler, “Voltage-dependent K+ channels in pancreatic beta cells: role, regulation and potential as therapeutic targets,” Diabetologia, vol. 46, no. 8, pp. 1046–1062, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Rafiq, G. da Silva Xavier, S. Hooper, and G. A. Rutter, “Glucose-stimulated preproinsulin gene expression and nuclear trans- location of pancreatic duodenum homeobox-1 require activation of phosphatidylinositol 3-kinase but not p38 MAPK/SAPK2,” Journal of Biological Chemistry, vol. 275, no. 21, pp. 15977–15984, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Trumper, A. Trumper, H. Trusheim, R. Arnold, B. Goke, and D. Horsch, “Integrative mitogenic role of protein kinase B/Akt in beta-cells,” Annals of the New York Academy of Sciences, vol. 921, pp. 242–250, 2000. View at Google Scholar
  33. E. Bernal-Mizrachi, W. Wen, S. Stahlhut, C. M. Welling, and M. A. Permutt, “Islet β cell expression of constitutively active Akt1/PKBα induces striking hypertrophy, hyperplasia, and hyperinsulinemia,” Journal of Clinical Investigation, vol. 108, no. 11, pp. 1631–1638, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. R. L. Tuttle, N. S. Gill, W. Pugh et al., “Regulation of pancreatic β-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα,” Nature Medicine, vol. 7, no. 10, pp. 1133–1137, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Arnette, T. B. Gibson, M. C. Lawrence et al., “Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic β cells,” Journal of Biological Chemistry, vol. 278, no. 35, pp. 32517–32525, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. E. Gomez, C. Pritchard, and T. P. Herbert, “cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate Raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic β-cells,” Journal of Biological Chemistry, vol. 277, no. 50, pp. 48146–48151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Puddu, R. Sanguineti, F. Mach, F. Dallegri, G. L. Viviani, and F. Montecucco, “Update on the protective molecular pathways improving pancreatic Beta-cell dysfunction,” Mediators of Inflammation, vol. 2013, Article ID 750540, 14 pages, 2013. View at Publisher · View at Google Scholar
  38. K. G. Harikumar, D. Wootten, D. I. Pinon et al., “Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, pp. 18607–18612, 2012. View at Google Scholar